N‑Cadherin Nanoantagonist Driven Mesenchymal-to-Epithelial Transition in Fibroblasts for Improving Reprogramming Efficiency

Induced pluripotent stem cells (iPSCs) hold promise in revolutionizing medicine; however, their application potential is limited because of low reprogramming efficiency. Mesenchymal-to-epithelial transition (MET) has been proved to involve reprogramming of somatic cells into iPSCs, making it a promi...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nano letters Ročník 21; číslo 13; s. 5540 - 5546
Hlavní autori:	Meng, Xia, Zhou, Anwei, Huang, Yu, Zhang, Yu, Xu, Yurui, Shao, Kaifeng, Ning, Xinghai
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States American Chemical Society 14.07.2021
Predmet:	Animals Cadherins - antagonists & inhibitors Cadherins - genetics Cellular Reprogramming Epithelial-Mesenchymal Transition Fibroblasts Gold Induced Pluripotent Stem Cells Metal Nanoparticles Mice ADH-1 functionalized gold nanoparticles induced pluripotent stem cells N-cadherin reprogramming efficiency mesenchymal-to-epithelial transition
ISSN:	1530-6984, 1530-6992, 1530-6992
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Induced pluripotent stem cells (iPSCs) hold promise in revolutionizing medicine; however, their application potential is limited because of low reprogramming efficiency. Mesenchymal-to-epithelial transition (MET) has been proved to involve reprogramming of somatic cells into iPSCs, making it a promising target for enhancing generation of iPSCs. Here, we nanoengineered N-cadherin-blocking peptide ADH-1 with gold nanoparticles, generating a multivalent N-cadherin antagonist (ADH-AuNPs), for improving reprogramming efficiency through driving cell MET. ADH-AuNPs exhibited good biocompatibility and showed higher N-cadherin inhibitory activity than ADH-1 due to multivalency, thereby enhancing cell-state reprogramming toward epithelial lineages. Particularly, ADH-AuNPs improved reprogramming efficiency by more than 7-fold after introduction of four Yamanaka factors. Importantly, ADH-AuNPs generated iPSCs displayed high stemness and pluripotency in vitro and in vivo. Therefore, we provide a cooperative strategy for promoting the iPSC generation efficacy.
AbstractList	Induced pluripotent stem cells (iPSCs) hold promise in revolutionizing medicine; however, their application potential is limited because of low reprogramming efficiency. Mesenchymal-to-epithelial transition (MET) has been proved to involve reprogramming of somatic cells into iPSCs, making it a promising target for enhancing generation of iPSCs. Here, we nanoengineered N-cadherin-blocking peptide ADH-1 with gold nanoparticles, generating a multivalent N-cadherin antagonist (ADH-AuNPs), for improving reprogramming efficiency through driving cell MET. ADH-AuNPs exhibited good biocompatibility and showed higher N-cadherin inhibitory activity than ADH-1 due to multivalency, thereby enhancing cell-state reprogramming toward epithelial lineages. Particularly, ADH-AuNPs improved reprogramming efficiency by more than 7-fold after introduction of four Yamanaka factors. Importantly, ADH-AuNPs generated iPSCs displayed high stemness and pluripotency in vitro and in vivo. Therefore, we provide a cooperative strategy for promoting the iPSC generation efficacy. Induced pluripotent stem cells (iPSCs) hold promise in revolutionizing medicine; however, their application potential is limited because of low reprogramming efficiency. Mesenchymal-to-epithelial transition (MET) has been proved to involve reprogramming of somatic cells into iPSCs, making it a promising target for enhancing generation of iPSCs. Here, we nanoengineered N-cadherin-blocking peptide ADH-1 with gold nanoparticles, generating a multivalent N-cadherin antagonist (ADH-AuNPs), for improving reprogramming efficiency through driving cell MET. ADH-AuNPs exhibited good biocompatibility and showed higher N-cadherin inhibitory activity than ADH-1 due to multivalency, thereby enhancing cell-state reprogramming toward epithelial lineages. Particularly, ADH-AuNPs improved reprogramming efficiency by more than 7-fold after introduction of four Yamanaka factors. Importantly, ADH-AuNPs generated iPSCs displayed high stemness and pluripotency and . Therefore, we provide a cooperative strategy for promoting the iPSC generation efficacy. Induced pluripotent stem cells (iPSCs) hold promise in revolutionizing medicine; however, their application potential is limited because of low reprogramming efficiency. Mesenchymal-to-epithelial transition (MET) has been proved to involve reprogramming of somatic cells into iPSCs, making it a promising target for enhancing generation of iPSCs. Here, we nanoengineered N-cadherin-blocking peptide ADH-1 with gold nanoparticles, generating a multivalent N-cadherin antagonist (ADH-AuNPs), for improving reprogramming efficiency through driving cell MET. ADH-AuNPs exhibited good biocompatibility and showed higher N-cadherin inhibitory activity than ADH-1 due to multivalency, thereby enhancing cell-state reprogramming toward epithelial lineages. Particularly, ADH-AuNPs improved reprogramming efficiency by more than 7-fold after introduction of four Yamanaka factors. Importantly, ADH-AuNPs generated iPSCs displayed high stemness and pluripotency in vitro and in vivo. Therefore, we provide a cooperative strategy for promoting the iPSC generation efficacy.Induced pluripotent stem cells (iPSCs) hold promise in revolutionizing medicine; however, their application potential is limited because of low reprogramming efficiency. Mesenchymal-to-epithelial transition (MET) has been proved to involve reprogramming of somatic cells into iPSCs, making it a promising target for enhancing generation of iPSCs. Here, we nanoengineered N-cadherin-blocking peptide ADH-1 with gold nanoparticles, generating a multivalent N-cadherin antagonist (ADH-AuNPs), for improving reprogramming efficiency through driving cell MET. ADH-AuNPs exhibited good biocompatibility and showed higher N-cadherin inhibitory activity than ADH-1 due to multivalency, thereby enhancing cell-state reprogramming toward epithelial lineages. Particularly, ADH-AuNPs improved reprogramming efficiency by more than 7-fold after introduction of four Yamanaka factors. Importantly, ADH-AuNPs generated iPSCs displayed high stemness and pluripotency in vitro and in vivo. Therefore, we provide a cooperative strategy for promoting the iPSC generation efficacy.
Author	Zhou, Anwei Meng, Xia Xu, Yurui Zhang, Yu Huang, Yu Shao, Kaifeng Ning, Xinghai
AuthorAffiliation	National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, School of Physics SARI Center for Stem Cell and Nanomedicine West China School of Medicine Shanghai Advanced Research Institute, Chinese Academy of Sciences National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Chemistry and Biomedicine Innovation Center, College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials
AuthorAffiliation_xml	– name: National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Chemistry and Biomedicine Innovation Center, College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials – name: National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, School of Physics – name: Shanghai Advanced Research Institute, Chinese Academy of Sciences – name: SARI Center for Stem Cell and Nanomedicine – name: West China School of Medicine
Author_xml	– sequence: 1 givenname: Xia surname: Meng fullname: Meng, Xia organization: National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Chemistry and Biomedicine Innovation Center, College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials – sequence: 2 givenname: Anwei surname: Zhou fullname: Zhou, Anwei organization: National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, School of Physics – sequence: 3 givenname: Yu surname: Huang fullname: Huang, Yu organization: West China School of Medicine – sequence: 4 givenname: Yu surname: Zhang fullname: Zhang, Yu organization: National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Chemistry and Biomedicine Innovation Center, College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials – sequence: 5 givenname: Yurui surname: Xu fullname: Xu, Yurui email: dg1834024@smail.nju.edu.cn organization: National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Chemistry and Biomedicine Innovation Center, College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials – sequence: 6 givenname: Kaifeng surname: Shao fullname: Shao, Kaifeng email: shaokf1@gmail.com organization: Shanghai Advanced Research Institute, Chinese Academy of Sciences – sequence: 7 givenname: Xinghai orcidid: 0000-0003-3453-9656 surname: Ning fullname: Ning, Xinghai email: xning@nju.edu.cn organization: National Laboratory of Solid State Microstructures, Collaborative Innovation Center of Advanced Microstructures, Chemistry and Biomedicine Innovation Center, College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/34161107$$D View this record in MEDLINE/PubMed
BookMark	eNqFkc1u1DAUhS1U1D_6BghlySbDdewkDjs0nUKl0kpVWUfXjjPjyrEH21NpFki8Aq_Ik-DRTLtgAat7r3y-I-ucM3LkvNOEvKUwo1DRD6jizKHzVqc0owpACHhFTmnNoGy6rjp62QU_IWcxPgJAx2o4JieM04ZSaE_Jj9vfP3_NcVjpYFxxm_3QJVx6Z2IqLoN50q74qqN2arWd0JbJl4u1SSttDdriIaCLJhnvikxfGRm8tBhTLEYfiutpHfyTccviXudtGXCadtdiHI0y2XL7hrwe0UZ9cZjn5NvV4mH-pby5-3w9_3RTIuMilXXXjJI2VQWjgAZAt5xSJpgSg2SqFU3NRwBsO9lVXFIENQjZNAw6NWgpOnZO3u998ze-b3RM_WSi0tai034T-6rmXLRC1FWWvjtIN3LSQ78OZsKw7Z8jywK-F6jgYwx6fJFQ6HfN9LmZ_rmZ_tBMxj7-hSmTcBddCmjs_2DYw7vXR78JLqf1b-QPNDCsFg
CitedBy_id	crossref_primary_10_3389_fonc_2023_1126721 crossref_primary_10_1002_adfm_202404563 crossref_primary_10_3390_biom14050509 crossref_primary_10_1016_j_jcis_2023_06_154 crossref_primary_10_1002_adma_202304172 crossref_primary_10_1016_j_bios_2024_116947 crossref_primary_10_1016_j_mehy_2023_111016 crossref_primary_10_1016_j_theriogenology_2023_01_008 crossref_primary_10_1016_j_cej_2025_164286
Cites_doi	10.1002/ijc.23027 10.1158/0008-5472.CAN-07-5949 10.1517/13543784.16.4.451 10.1038/nrm.2016.8 10.1021/acs.accounts.6b00506 10.1038/labinvest.2017.56 10.1038/nbt1418 10.1016/j.stem.2010.04.015 10.1038/s41586-018-0016-3 10.1038/nrg3473 10.1038/nm.2236 10.1016/j.cell.2006.07.024 10.1515/hsz-2016-0181 10.1016/j.cell.2007.11.019 10.3389/fnmol.2016.00078 10.1038/s41556-018-0136-x 10.1038/embor.2011.88 10.3390/cells10020284 10.1016/j.stemcr.2017.07.002 10.1038/ncb0511-497 10.1016/j.stem.2009.12.001 10.1002/cpcb.51 10.1089/scd.2019.0188 10.1016/j.stem.2010.04.014
ContentType	Journal Article
Copyright	2021 American Chemical Society
Copyright_xml	– notice: 2021 American Chemical Society
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1021/acs.nanolett.1c00880
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Engineering
EISSN	1530-6992
EndPage	5546
ExternalDocumentID	34161107 10_1021_acs_nanolett_1c00880 b486590831
Genre	Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	- .K2 123 3RI 4.4 55A 5VS 7~N AABXI ABFRP ABMVS ABPTK ABUCX ACGFS ACS AEESW AENEX AFEFF AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CS3 DU5 EBS ED ED~ F5P GGK GNL IH9 IHE JG JG~ K2 PK8 RNS ROL TN5 UI2 VF5 VG9 W1F X --- -~X 6P2 AAHBH AAYXX ABBLG ABJNI ABLBI ABQRX ACBEA ADHLV CITATION CUPRZ CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-a348t-596fb16220f80600e7411383c8db3c78654f00a79b924b1a0cd8b66309cdeb893
IEDL.DBID	ACS
ISICitedReferencesCount	12
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000674354200013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1530-6984 1530-6992
IngestDate	Fri Jul 11 11:49:05 EDT 2025 Mon Jul 21 05:49:45 EDT 2025 Tue Nov 18 21:18:06 EST 2025 Sat Nov 29 06:17:18 EST 2025 Fri Jul 16 16:58:44 EDT 2021
IsPeerReviewed	true
IsScholarly	true
Issue	13
Keywords	ADH-1 functionalized gold nanoparticles induced pluripotent stem cells N-cadherin reprogramming efficiency mesenchymal-to-epithelial transition
Language	English
License	https://doi.org/10.15223/policy-029 https://doi.org/10.15223/policy-037 https://doi.org/10.15223/policy-045
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-a348t-596fb16220f80600e7411383c8db3c78654f00a79b924b1a0cd8b66309cdeb893
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ORCID	0000-0003-3453-9656
PMID	34161107
PQID	2544878852
PQPubID	23479
PageCount	7
ParticipantIDs	proquest_miscellaneous_2544878852 pubmed_primary_34161107 crossref_primary_10_1021_acs_nanolett_1c00880 crossref_citationtrail_10_1021_acs_nanolett_1c00880 acs_journals_10_1021_acs_nanolett_1c00880
ProviderPackageCode	JG~ 55A AABXI GNL VF5 7~N VG9 3RI GGK W1F ABFRP ACS AEESW AFEFF .K2 ABMVS ABUCX IH9 BAANH AQSVZ ED~ UI2
PublicationCentury	2000
PublicationDate	20210714 2021-07-14
PublicationDateYYYYMMDD	2021-07-14
PublicationDate_xml	– month: 07 year: 2021 text: 20210714 day: 14
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Nano letters
PublicationTitleAlternate	Nano Lett
PublicationYear	2021
Publisher	American Chemical Society
Publisher_xml	– name: American Chemical Society
References	ref9/cit9 ref17/cit17 ref6/cit6 ref10/cit10 ref3/cit3 ref18/cit18 ref19/cit19 ref21/cit21 ref11/cit11 ref12/cit12 ref15/cit15 ref16/cit16 ref22/cit22 ref23/cit23 ref13/cit13 ref14/cit14 ref8/cit8 ref5/cit5 ref2/cit2 ref4/cit4 ref1/cit1 ref24/cit24 ref20/cit20 ref7/cit7
References_xml	– ident: ref23/cit23 doi: 10.1002/ijc.23027 – ident: ref21/cit21 doi: 10.1158/0008-5472.CAN-07-5949 – ident: ref24/cit24 doi: 10.1517/13543784.16.4.451 – ident: ref8/cit8 doi: 10.1038/nrm.2016.8 – ident: ref22/cit22 doi: 10.1021/acs.accounts.6b00506 – ident: ref14/cit14 doi: 10.1038/labinvest.2017.56 – ident: ref11/cit11 doi: 10.1038/nbt1418 – ident: ref16/cit16 doi: 10.1016/j.stem.2010.04.015 – ident: ref6/cit6 doi: 10.1038/s41586-018-0016-3 – ident: ref13/cit13 doi: 10.1038/nrg3473 – ident: ref20/cit20 doi: 10.1038/nm.2236 – ident: ref2/cit2 doi: 10.1016/j.cell.2006.07.024 – ident: ref10/cit10 doi: 10.1515/hsz-2016-0181 – ident: ref1/cit1 doi: 10.1016/j.cell.2007.11.019 – ident: ref5/cit5 doi: 10.3389/fnmol.2016.00078 – ident: ref12/cit12 doi: 10.1038/s41556-018-0136-x – ident: ref17/cit17 doi: 10.1038/embor.2011.88 – ident: ref19/cit19 doi: 10.3390/cells10020284 – ident: ref18/cit18 doi: 10.1016/j.stemcr.2017.07.002 – ident: ref4/cit4 doi: 10.1038/ncb0511-497 – ident: ref9/cit9 doi: 10.1016/j.stem.2009.12.001 – ident: ref3/cit3 doi: 10.1002/cpcb.51 – ident: ref7/cit7 doi: 10.1089/scd.2019.0188 – ident: ref15/cit15 doi: 10.1016/j.stem.2010.04.014
SSID	ssj0009350
Score	2.4319556
Snippet	Induced pluripotent stem cells (iPSCs) hold promise in revolutionizing medicine; however, their application potential is limited because of low reprogramming...
SourceID	proquest pubmed crossref acs
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	5540
SubjectTerms	Animals Cadherins - antagonists & inhibitors Cadherins - genetics Cellular Reprogramming Epithelial-Mesenchymal Transition Fibroblasts Gold Induced Pluripotent Stem Cells Metal Nanoparticles Mice
Title	N‑Cadherin Nanoantagonist Driven Mesenchymal-to-Epithelial Transition in Fibroblasts for Improving Reprogramming Efficiency
URI	http://dx.doi.org/10.1021/acs.nanolett.1c00880 https://www.ncbi.nlm.nih.gov/pubmed/34161107 https://www.proquest.com/docview/2544878852
Volume	21
WOSCitedRecordID	wos000674354200013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVABC databaseName: American Chemical Society Journals customDbUrl: eissn: 1530-6992 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009350 issn: 1530-6984 databaseCode: ACS dateStart: 20010101 isFulltext: true titleUrlDefault: https://pubs.acs.org/action/showPublications?display=journals providerName: American Chemical Society
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT-MwELZ4HeAALOxCeclIXDiYdZw0to-otOJChbQg9RaNnWR3pTZBTUDigMRf4C_ySxi7aXlICHFMFFvJeOz5vtjzDSFHAgFbymPOcslTJCgWmJbCMisxnpk0NxLAF5uQ_b4aDPTlK1H8uIMvgt9gq5MCihI_oz4JLMYshRR9USDSdR592vnzKrIb-oqsOImREmkVTVPlPunFBSRbvQ9In6BMH216a999z3Wy2uBKejpxhB9kLis2yMobtcFN8tB_fnzqQOoz_iguqyVaFf6WTjuXno3dskcvXDKS_Xc_giGrS9a9cSkbQ_RR6oOaP99FsXUPWXZpEHnXFUXYS2f_Jigi-smRr5G76nqFCpfe-ZNc97pXnXPWVF9gEEaqZm0d5yaIheC5wsHkGWKPAPmsVakJrVRxO8o5B6kNUjgTALepMohfuLZpZhAG_SILRVlk24TqQEOG0DSWoY4yENqpvCng7Tw1AEq2yDFaL2lmT5X4jXERJO7m1KRJY9IWCafDldhGxtxV0xh-0YrNWt1MZDy-eP5w6gkJzje3iQJFVt5WiZN0U1KptmiRrYmLzHoMHVtEPr3zje_ZJcvCHZNxWp3RHlmox7fZPlmyd_X_anxA5uVAHXgvfwGD9f4Q
linkProvider	American Chemical Society
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6tClLpgUcL7fIoRuLSg6nztH2sll21ol0hUaTeIttJSqVtUm3SSj0g8Rf4i_wSZrzJLhyqCo6xYssZjz3fF3s-A7wPEbDlIhW8lCJHguIM1zJ03EmMZzYvrTTGXzYhp1N1dqY_DyDpc2GwEw221PhN_JW6QLBPZZWpavya9kPgMHQpZOoPEoyw5N4Hoy8rrd3IX8yKcxmZkVZxnzF3RysUl1zzd1y6A2z6oDN58p_dfQqPO5TJDhZu8QwGRbUJG39oD27B9-mvHz9HJvf5fwwX2RptbM5rUtJlH-e0CLITSk1y324vzYy3NR9fUQLHDD2W-RDnT3sxrD1Bzl1bxOFtwxAEs-WfCob4fnEA7JKexl6vgpI9n8PXyfh0dMi7uxi4iWLV8kSnpQ3SMBSlwqEVBSKRANmtU7mNnFRpEpdCGKktEjobGOFyZRHNCO3ywiIoegFrVV0VO8B0oE2BQDWVkY4LE2rSfFNGJGVujVFyCHtovaybS03mt8nDIKPC3qRZZ9IhRP2oZa4TNae7NWb31OLLWlcLUY973n_XO0SGs4-2VExV1NdNRgJvSiqVhEPYXnjKssWIuCOy65f_8D1vYf3w9OQ4Oz6afnoFj0I6QEMqnvFrWGvn18UbeOhu2otmvutd_jcJ_wWd
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NTtwwELYqqFA5QAsFFmjrSr30YHB-bR9Xy65atV0htZW4Rf5JAGlJVpssEgckXoFX5EmY8WYXOCBU9RgrtpzxjOeb2PMNIV9CAGyOp5wVgjsIUKxmSoSWWQH-zLjCCK19sQkxHMqTE3X8qNQXTKKGkWp_iI9WPXZFyzAQHGJ7qcsKvqg5CCy4LwnR-nICPh1VvNv7_cC3G_nirGDPEB0pGc-z5p4ZBX2TrZ_6pmcAp3c8g_X_mPJbstaiTdqdqcc78iovN8jqIw7CTXI9vLu57Wnn8wApbLYVyFqfVsioS48muBnSX5iiZM-uLvSINRXrjzGRYwSaS72r87e-KPQeQOxdGcDjTU0BDNPFHwsKOH92EewCn_qetwKTPt-Tv4P-n9431tZkYDqKZcMSlRYmSMOQFxKWmOeASAKIcq10JrJCpklccK6FMhDYmUBz66QBVMOVdbkBcLRFlsqqzHcIVYHSOQDWVEQqznWokPtNap4UzmgtRYd8BellrU3VmT8uD4MMG-cizVqRdkg0X7nMtuTmWGNj9EIvtug1npF7vPD-57lSZGCFeLSiy7ya1hkSvUkhZRJ2yPZMWxYjRhhDQpS9-w_f84msHB8Nsp_fhz_2yJsQ79EgmWe8T5aayTT_QF7by-a8nnz0Wn8PRI0IFw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=N-Cadherin+Nanoantagonist+Driven+Mesenchymal-to-Epithelial+Transition+in+Fibroblasts+for+Improving+Reprogramming+Efficiency&rft.jtitle=Nano+letters&rft.au=Meng%2C+Xia&rft.au=Zhou%2C+Anwei&rft.au=Huang%2C+Yu&rft.au=Zhang%2C+Yu&rft.date=2021-07-14&rft.eissn=1530-6992&rft.volume=21&rft.issue=13&rft.spage=5540&rft_id=info:doi/10.1021%2Facs.nanolett.1c00880&rft_id=info%3Apmid%2F34161107&rft.externalDocID=34161107
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1530-6984&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1530-6984&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1530-6984&client=summon